Curtiss-Wright (NYSE:CW – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Monday.
Other analysts have also recently issued reports about the company. Stifel Nicolaus upped their price target on Curtiss-Wright from $310.00 to $318.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Robert W. Baird upped their price target on Curtiss-Wright from $300.00 to $312.00 and gave the company an “outperform” rating in a research report on Friday, August 9th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Curtiss-Wright presently has an average rating of “Moderate Buy” and an average target price of $307.50.
Check Out Our Latest Report on Curtiss-Wright
Curtiss-Wright Stock Performance
Curtiss-Wright (NYSE:CW – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The aerospace company reported $2.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.43. Curtiss-Wright had a return on equity of 17.07% and a net margin of 13.05%. The business had revenue of $785.00 million for the quarter, compared to analysts’ expectations of $735.82 million. During the same period in the previous year, the business posted $2.15 earnings per share. Curtiss-Wright’s quarterly revenue was up 11.4% on a year-over-year basis. Sell-side analysts forecast that Curtiss-Wright will post 10.55 EPS for the current year.
Insiders Place Their Bets
In other Curtiss-Wright news, Director Glenda J. Minor sold 500 shares of the business’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $302.80, for a total value of $151,400.00. Following the transaction, the director now owns 1,382 shares of the company’s stock, valued at $418,469.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have acquired 120 shares of company stock valued at $27,914. 0.67% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Curtiss-Wright
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Curtiss-Wright by 0.5% during the first quarter. Vanguard Group Inc. now owns 3,657,854 shares of the aerospace company’s stock valued at $936,191,000 after acquiring an additional 18,939 shares during the period. Boston Partners lifted its stake in Curtiss-Wright by 3.0% in the first quarter. Boston Partners now owns 1,393,662 shares of the aerospace company’s stock valued at $356,684,000 after buying an additional 40,657 shares during the period. Global Alpha Capital Management Ltd. lifted its stake in Curtiss-Wright by 41.7% in the first quarter. Global Alpha Capital Management Ltd. now owns 352,813 shares of the aerospace company’s stock valued at $90,299,000 after buying an additional 103,780 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in Curtiss-Wright by 30,079.2% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 302,396 shares of the aerospace company’s stock valued at $81,943,000 after buying an additional 301,394 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in Curtiss-Wright by 18.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 247,225 shares of the aerospace company’s stock valued at $55,079,000 after buying an additional 38,986 shares during the period. Institutional investors and hedge funds own 82.71% of the company’s stock.
Curtiss-Wright Company Profile
Curtiss-Wright Corporation, together with its subsidiaries, provides engineered products, solutions, and services mainly to aerospace and defense, commercial power, process, and industrial markets worldwide. It operates through three segments: Aerospace & Industrial, Defense Electronics, and Naval & Power.
Recommended Stories
- Five stocks we like better than Curtiss-Wright
- Energy and Oil Stocks Explained
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Find Undervalued Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Roth IRA Calculator: Calculate Your Potential Returns
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Curtiss-Wright Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curtiss-Wright and related companies with MarketBeat.com's FREE daily email newsletter.